EGETIS THERAPEUTICS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.96 SEK | +9.09% |
|
+10.83% | +24.73% |
Chart calendar Egetis Therapeutics AB
3fe57c37ef60d43.TkF1_IkaVQT4Shm7iiH9Lscl6zPqUmL_aebGxxjzVks.GApNqeQvYFbLMkGJ0BKrTIUcmFaAAzKdIK-ps0iBbhkccBiMwU46QpYwLQ~7029fcf7928ab1a23f91ea669497bd6f
Upcoming events on Egetis Therapeutics AB
Past events on Egetis Therapeutics AB
| Today | Q1 2024 Earnings Release |
| 18/04/2024 16:50 | Redeye Investor Forum |
| 04/03/2024 | Carnegie Healthcare Conference |
| 21/02/2024 | Q4 2023 Earnings Release |
| 18/12/2023 | Investor Day |
| 07/11/2023 | Q3 2023 Earnings Release |
| 21/08/2023 | Q2 2023 Earnings Release |
| 30/05/2023 05:00 | ABGSC Life Science Summit |
| 26/04/2023 | Annual General Meeting |
| 25/04/2023 | Q1 2023 Earnings Release |
| 21/02/2023 | FY 2022 Earnings Release |
| 07/11/2022 | Q3 2022 Earnings Release |
| 18/10/2022 | American Thyroid Association Meeting |
| 13/10/2022 12:00 | Capital Markets Day |
| 02/10/2022 | International Child Neurology Congress |
| 14/09/2022 | European Society of Paediatric Endocrinology Meeting |
| 09/09/2022 | European Thyroid Association Meeting |
| 06/09/2022 | Pareto Securities Healthcare Conference |
| 30/08/2022 | Redeye Late Stage Life Science Day |
| 29/08/2022 | Society for the Study of Inborn Errors of Metabolism Symposium |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 82,6 73,0 13.07% | 40,7 39,8 2.28% | 38,5 49,1 -21.56% | 22,6 29,2 -22.63% | 57,6 35,4 62.54% | 65,1 |
|
EBITDA Million SEK | Released Forecast Spread | -66,5 -89,2 25.49% | -178 -133 -33.78% | -103 -127 19.03% | -195 -163 -19.8% | -321 -286 -12.41% | -286 |
|
EBIT Million SEK | Released Forecast Spread | -66,7 -89,4 25.43% | -178 -133 -34.01% | -106 -128 17.18% | -198 -165 -19.71% | -325 -288 -12.92% | -289 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -61,4 -76,7 19.9% | -179 -131 -36.83% | -105 -128 18.52% | -194 -159 -21.69% | -327 -287 -14.05% | -291 |
|
Net income Million SEK | Released Forecast Spread | -61,4 -76,7 19.9% | -179 -131 -36.83% | -105 -128 18.52% | -194 -159 -21.69% | -327 -287 -14.08% | -291 |
|
EPS SEK | Released Forecast Spread | -1,20 -1,49 19.24% | -2,70 -1,35 -100.44% | -0,60 -0,78 23.04% | -1,00 -0,85 -17.19% | -1,30 -1,22 -6.57% | -0,95 |
| Announcement Date | 18/02/20 | 17/02/21 | 17/02/22 | 22/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 3,51 4,00 -12.23% | 5,02 10,4 -51.61% | 5,10 10,4 -50.87% | 5,70 10,4 -45.09% | 6,80 5,62 20.98% | 5,90 5,25 12.3% | 12,2 5,25 132.2% | 32,6 8,30 292.77% | 10,0 | 9,00 | 10,0 | 10,0 | |
|
EBITDA Million SEK | Released Forecast Spread | -31,9 -37,0 13.65% | -34,3 -45,4 24.38% | -54,7 -45,4 -20.57% | -77,5 -45,4 -70.83% | -74,0 -82,0 9.76% | -79,4 -71,7 -10.79% | -85,6 -73,1 -17.17% | -82,2 -83,9 2.01% | -86,0 | -85,0 | -85,0 | -85,0 | |
|
EBIT Million SEK | Released Forecast Spread | -32,6 -37,0 11.84% | -35,0 -45,4 22.89% | -55,4 -45,4 -22.11% | -78,2 -45,4 -72.37% | -74,9 -82,0 8.66% | -80,3 -71,7 -12.05% | -86,5 -73,1 -18.4% | -83,1 -83,9 0.93% | -86,0 | -85,0 | -85,0 | -85,0 | |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -32,1 -38,4 16.47% | -33,2 -48,0 30.77% | -53,9 -48,0 -12.24% | -77,8 -48,0 -62.02% | -74,9 -80,8 7.26% | -79,5 -71,0 -11.97% | -86,2 -72,7 -18.57% | -86,1 -87,3 1.34% | -89,4 | -88,4 | -94,3 | -94,6 | |
|
Net income Million SEK | Released Forecast Spread | -32,1 -38,4 16.47% | -28,8 | -33,2 -48,0 30.77% | -53,1 -48,0 -10.56% | -77,8 -48,0 -62.02% | -74,9 -80,8 7.26% | -79,5 -71,0 -11.97% | -86,2 -72,7 -18.57% | -86,3 -87,3 1.11% | -89,4 | -88,4 | -94,3 | -94,6 |
|
EPS SEK | Released Forecast Spread | -0,20 -0,23 13.98% | -0,20 | -0,20 -0,22 10.63% | -0,30 -0,22 -34.06% | -0,40 -0,22 -78.75% | -0,30 -0,35 13.79% | -0,30 -0,28 -5.46% | -0,30 -0,26 -14.6% | -0,30 -0,32 6.81% | -0,31 | -0,30 | -0,32 | -0,31 |
| Announcement Date | 17/02/22 | 26/04/22 | 19/08/22 | 08/11/22 | 22/02/23 | 26/04/23 | 22/08/23 | 08/11/23 | 22/02/24 | - | - | - | - |
More events
Past sector events for Egetis Therapeutics AB
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:00 | AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release |
| 01/05/2024 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | GERON CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EGTX Stock
- Calendar Egetis Therapeutics AB
